Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer [Phase 2]
A Phase 2 trial evaluating Onartuzumab (MetMAb) with the mFOLFOX6 regimen in metastatic HER2-negative gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Metronomic Chemotherapy in Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating metronomic chemotherapy for metastatic or locally advanced gastric cancer; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer [Phase 3]
This document provides an update on a Phase 3 trial evaluating apatinib as maintenance therapy after first-line treatment for locally advanc…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy [Phase 2]
A Phase II study evaluating pemetrexed in patients with advanced or recurrent gastric cancer after prior chemotherapy has completed.
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer [Phase 2]
This clinical trial update describes a Phase 2 study evaluating conversion therapy with S1/paclitaxel chemotherapy plus apatinib for unresec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-07-25Clinical Trial Update: The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using Immunohistochemistry
This is a clinical study investigating HER-2 expression in gastric cancer using immunohistochemistry on extra-tumor tissue paraffin blocks.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach [Phase 2]
Phase 2 trial evaluating the combination of docetaxel and irinotecan in patients with advanced esophageal or gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach [Phase 1]
This Phase 1 trial evaluated the combination of radiation therapy and chemotherapy in patients with pancreatic cancer or gastric cancer; the…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Irinotecan in Treating Patients With Advanced Cancer of the Stomach [Phase 2]
Phase 2 clinical trial evaluating irinotecan in patients with advanced gastric cancer and esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: The Effect of Chemotherapy and Surgery for Cancer on Exercise Capacity
A completed clinical trial evaluated how chemotherapy and surgery for esophageal, gastric, and duodenal cancers affect patients' exercise ca…
-
CLINICAL_TRIALS research · 2016-07-11Clinical Trial Update: Permission to Collect Blood Over Time for Research
A terminated Stanford clinical trial update describes permission to collect blood samples over time for research in pancreatic cancer and ot…
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer [Phase 1]
Phase 1 safety study update for GC1118, a recombinant human anti-EGFR antibody, in advanced solid cancers including gastric and colorectal c…
-
CLINICAL_TRIALS research · 2016-06-29Clinical Trial Update: A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating the efficacy and tolerability of the TEGAFOX sequential S-1 regimen as adjuvant chemotherapy for ga…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer [Phase 2]
Phase 2 trial evaluating pertuzumab with trastuzumab and chemotherapy in HER2-positive advanced gastric cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer [Phase 1, Phase 2]
A clinical trial update evaluating the combination of trastuzumab with expanded natural killer cells for HER2-positive gastric cancer across…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors [Phase 2]
Phase 2 trial update evaluating docetaxel with or without low-dose, short-course sunitinib in refractory solid tumors, including breast canc…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update for trastuzumab combined with TS-ONE and cisplatin as first-line therapy for HER2-positive advanced gastric ca…
-
CLINICAL_TRIALS research · 2016-06-22Clinical Trial Update: A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients [Phase 2]
Phase 2 clinical trial in Singapore evaluating genomic-guided standard-of-care chemotherapy for recurrent/advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer [Phase 1, Phase 2]
A clinical trial update evaluating NK cell infusions in combination with trastuzumab for HER2-positive breast and gastric cancer in Phase 1/…
-
CLINICAL_TRIALS research · 2016-06-22Clinical Trial Update: Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for the OTSGC-A24 vaccine in advanced gastric cancer, sponsored by National University Hospital, Singapore…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer [Phase 1]
A Phase 1 trial of sunitinib, irinotecan, fluorouracil, and leucovorin in advanced gastric and esophageal cancers has been terminated.
-
CLINICAL_TRIALS research · 2016-06-20Clinical Trial Update: Comparison of Vagus Nerve-preserving RADG and Conventional RADG for AGC [NA]
This clinical trial update compares vagus nerve-preserving robotic-assisted distal gastrectomy (RADG) with conventional RADG for gastric can…
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer [Phase 3]
Phase III trial of apatinib for advanced or metastatic gastric cancer has completed and posted results in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: First Line Chemotherapy for Advanced Cancer [Phase 2]
Phase 2 trial evaluating first-line chemotherapy for advanced gastric cancer has been terminated.
-
CLINICAL_TRIALS research · 2016-06-14Clinical Trial Update: SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating the SOX regimen (S-1 plus oxaliplatin) as adjuvant chemotherapy for resectable gastric cancer…